✦ LIBER ✦

Adjuvant therapy of triple negative breast cancer

✍ Scribed by Edith A. Perez; Alvaro Moreno-Aspitia; E. Aubrey Thompson; Cathy A. Andorfer

Publisher: Springer US
Year: 2010
Tongue: English
Weight: 252 KB
Volume: 120
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-010-0736-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Triple-negative breast cancer

✍ Rupert Bartsch; Reinhard Ziebermayr; Christoph C. Zielinski; Guenther G. Steger 📂 Article 📅 2010 🏛 Springer Vienna 🌐 German ⚖ 165 KB

Breast cancer adjuvant therapy

✍ Paul P. Carbone 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 755 KB

Combined modality trials in early breast cancer have been underway since the 1960s and results are available to indicate varying degrees of success in Stage I and 11. The trials have involved more than 29,000 women in 61 randomized trials. The recommendations can be summarized by stage, estrogen rec

Adjuvant therapy of breast cancer

✍ Nancy E. Davidson; Martin D. Abeloff 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 605 KB

About 180,000 American women will be diagnosed with early stage breast cancer during 1993. In many of these patients breast cancer is a systemic disease at diagnosis and thus not curable by local treatment alone. The development of optimal forms of systemic adjuvant therapy has been a major area of

Adjuvant therapy for stage II, estrogen

Adjuvant therapy for stage II, estrogen receptor negative breast cancer

✍ William A. Knight; Gary M. Clark; C. Kent Osborne; William L. McGuire 📂 Article 📅 1981 🏛 Springer US 🌐 English ⚖ 283 KB

Characteristics of triple-negative breas

Characteristics of triple-negative breast cancer

✍ Tim C. de Ruijter; Jürgen Veeck; Joep P. J. de Hoon; Manon van Engeland; Viviann 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 254 KB

## Background Triple-negative breast cancers (TNBC) neither express hormone receptors, nor overexpress HER2. They are associated with poor prognosis, as defined by low five-year survival and high recurrence rates after adjuvant therapy. Overall, TNBC share striking similarities with basal-like brea

Adjuvant therapy for breast cancer

✍ S. Rodenhuis; E. J. T. Rutgers 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views

Requires sophistication